Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L129342-5mg | 5mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $64.90 | |
L129342-25mg | 25mg | In stock | $292.90 | |
L129342-100mg | 100mg | In stock | $1,053.90 | |
L129342-250mg | 250mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $2,369.90 | |
L129342-1g | 1g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $8,529.90 | |
L129342-5g | 5g | In stock | $38,381.90 |
Hexokinase inhibitor
Synonyms | lonidamine|50264-69-2|1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid|Diclondazolic acid|Doridamina|DICA|Lonidamina|Lonidaminum|1-[(2,4-dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid|Lonidamin|AF 1890|C15H10Cl2N2O2|1-(2,4-Dichlorbenzyl)-indazol |
---|---|
Specifications & Purity | ≥99% |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Dry ice |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of mitochondrial pyruvate carrier 1 like;Inhibitor of mitochondrial pyruvate carrier 2 |
Product Description | Product Describtion: Lonidamine is an indazole compound that has been reported to inhibit angiogenic-related endothelial cell functions. This compound has been found to trigger apoptosis in endothelial cells and cause a decrease in proliferation, migration, invasion, and morphogenesis. The apoptotic effects of Lonidamine have been demonstrated to be due to Bax, Bid, caspase-3, and caspase-9 activation, as well as cytochrome c release. Futher studies show that Lonidamine prevents cellular energy metabolism via HXK (hexokinase) inhibition. This compound also blocks CFTR Cl- channels in vitro. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid |
---|---|
INCHI | InChI=1S/C15H10Cl2N2O2/c16-10-6-5-9(12(17)7-10)8-19-13-4-2-1-3-11(13)14(18-19)15(20)21/h1-7H,8H2,(H,20,21) |
InChi Key | WDRYRZXSPDWGEB-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O |
Isomeric SMILES | C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O |
WGK Germany | 3 |
Alternate CAS | 50264-69-2 |
PubChem CID | 39562 |
NSC Number | 741419 |
MeSH Entry Terms | 1-(2,4-dichlorobenzyl)indazole-3-carboxylic acid;AF 1890;diclondazolic acid;lonidamine |
Molecular Weight | 321.16 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2228751 | Certificate of Analysis | Jun 11, 2024 | L129342 |
H1808094 | Certificate of Analysis | Jan 17, 2024 | L129342 |
H1808092 | Certificate of Analysis | Jan 17, 2024 | L129342 |
C23211020 | Certificate of Analysis | Jun 12, 2022 | L129342 |
C23211021 | Certificate of Analysis | Jun 12, 2022 | L129342 |
C23241044 | Certificate of Analysis | Jun 12, 2022 | L129342 |
G2228358 | Certificate of Analysis | Jun 12, 2022 | L129342 |
G2228363 | Certificate of Analysis | Jun 12, 2022 | L129342 |
J2311063 | Certificate of Analysis | Jun 12, 2022 | L129342 |
J2327073 | Certificate of Analysis | Jun 12, 2022 | L129342 |
D1607152 | Certificate of Analysis | Jan 19, 2022 | L129342 |
Solubility | Soluble in ethanol (5 mM), DMSO (100 mM), CHCl3/MeOH 1/1 (9.80-10.20 mg/ml), water (<1 mg/ml at 25° C), DMSO (64 mg/ml at 25° C), and ethanol (<1 mg/ml at 25° C). |
---|---|
Sensitivity | Air Sensitive |
Melt Point(°C) | 210 °C |
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H351:Suspected of causing cancer H302:Harmful if swallowed H360:May damage fertility or the unborn child |
Precautionary Statements | P280:Wear protective gloves/protective clothing/eye protection/face protection. P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. |
WGK Germany | 3 |